AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Prochazkova, A Liu, SL Friess, H Aebi, S Thormann, W
Citation: A. Prochazkova et al., Determination of 5-fluorouracil and 5-fluoro-2 '-deoxyuridine-5 '-monophosphate in pancreatic cancer cell line and other biological materials using capillary electrophoresis, J CHROMAT A, 916(1-2), 2001, pp. 215-224

Authors: Novak, U Grob, TJ Baskaynak, G Peters, UR Aebi, S Zwahlen, D Tschan, MP Kreuzer, KA Leibundgut, EO Cajot, JF Tobler, A Fey, MF
Citation: U. Novak et al., Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia, ANN ONCOL, 12(7), 2001, pp. 981-986

Authors: Aebi, S Castiglione-Gertsch, M
Citation: S. Aebi et M. Castiglione-gertsch, High-dose chemotherapy for ovarian cancer: Are we ready to go?, ANN ONCOL, 12(5), 2001, pp. 583-584

Authors: Cenni, B Aebi, S Nehme, A Christen, RD
Citation: B. Cenni et al., Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway, CANC CHEMOT, 47(5), 2001, pp. 397-403

Authors: Rauch, DP Maurer, CA Aebi, S Pampallona, S Friess, H Ludwig, CU Buchler, MW Borner, MM
Citation: Dp. Rauch et al., Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer, ONCOL-BASEL, 60(1), 2001, pp. 43-48

Authors: Xu, ZW Friess, H Solioz, M Aebi, S Korc, M Kleeff, J Buchler, MW
Citation: Zw. Xu et al., Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine, INT J CANC, 94(2), 2001, pp. 268-274

Authors: Pabst, T Peters, UR Tinguely, M Schwaller, J Tschan, M Aebi, S Vonlanthen, S Borisch, B Betticher, DC Zimmermann, A Tobler, A Fey, MF
Citation: T. Pabst et al., Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14(ARF) /p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia, LEUK LYMPH, 37(5-6), 2000, pp. 639-648

Authors: Balli, S Fey, MF Hanggi, W Zwahlen, D Berclaz, G Dreher, E Aebi, S
Citation: S. Balli et al., Ovarian cancer: an institutional review of patterns of care, health insurance and prognosis, EUR J CANC, 36(16), 2000, pp. 2061-2068

Authors: de las Alas, MM Christen, RD Gately, DP Weiner, DE Benbatoul, K Kirmani, S D'Agostino, HR Plaxe, SC Darrah, D McClay, EF Aebi, S Howell, SB Los, G
Citation: Mm. De Las Alas et al., Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel, CANC CHEMOT, 45(5), 2000, pp. 381-388

Authors: Aebi, S Gelber, S Castiglione-Gertsch, M Coates, AS Goldhirsch, A
Citation: S. Aebi et al., False negatives in oestrogen-receptor assay - Reply, LANCET, 356(9233), 2000, pp. 944-945

Authors: Aebi, S Gelber, S Castiglione-Gertsch, M Gelber, RD Collins, J Thurlimann, B Rudenstam, CM Lindtner, J Crivellari, D Cortes-Funes, H Simoncini, E Werner, ID Coates, AS Goldhirsch, A
Citation: S. Aebi et al., Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?, LANCET, 355(9218), 2000, pp. 1869-1874

Authors: Zwahlen, D Tschan, MP Grob, TJ Peters, UR Fink, D Haenggi, W Altermatt, HJ Cajot, JF Tobler, A Fey, MF Aebi, S
Citation: D. Zwahlen et al., Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours, INT J CANC, 88(1), 2000, pp. 66-70

Authors: Berclaz, G Hofmann, C Aebi, S Brugger, S Fey, M Hanggi, W Dreher, E
Citation: G. Berclaz et al., Staging breast cancer: Too many studies?, GEBURTSH FR, 60(8), 2000, pp. 418-422

Authors: Buetler, TM Wilder-Smith, OHG Wilder-Smith, CH Aebi, S Cerny, T Brenneisen, R
Citation: Tm. Buetler et al., Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers, BR J ANAEST, 84(1), 2000, pp. 97-99

Authors: Zahnd, D Aebi, S Rusterholz, S Fey, MF Borner, MM
Citation: D. Zahnd et al., A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices, ANN ONCOL, 10(6), 1999, pp. 727-729

Authors: Aebi, S Schnider, TW Los, G Heath, DD Darrah, D Kirmani, S McClay, EF D'Agostino, H Plaxe, SC Fink, D De las Alas, MM Howell, SB Christen, RD
Citation: S. Aebi et al., A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel, CANC CHEMOT, 44(3), 1999, pp. 259-265

Authors: Cenni, B Kim, HK Bubley, GJ Aebi, S Fink, D Teicher, BA Howell, S Christen, RD
Citation: B. Cenni et al., Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin, BR J CANC, 80(5-6), 1999, pp. 699-704
Risultati: 1-17 |